Related Experiment Video
Updated: Jan 31, 2026
07:59
Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
7.1K
Systemic therapy for metastatic colorectal cancer
1Gastrointestinal Oncology Service at Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA. saltzl@mskcc.org
Summary
Targeted agents offer modest survival benefits in advanced colorectal cancer (CRC) treatment. Clinicians should weigh statistical versus clinical significance and toxicity when personalizing therapy for metastatic CRC.
Area of Science:
- Oncology
- Medical Pharmacology
Background:
- Advanced colorectal cancer (CRC) treatment often involves irinotecan and oxaliplatin.
- Targeted agents have been added to standard chemotherapy regimens for metastatic CRC.
- Recent additions include regorafenib and ziv-aflibercept.
Purpose of the Study:
- To review landmark trials of targeted agents in metastatic CRC.
- To discuss the clinical significance of statistically significant survival improvements.
- To highlight the importance of considering toxicity profiles in treatment individualization.
Main Methods:
- Review of landmark clinical trials in advanced colorectal cancer.
- Analysis of progression-free and overall survival data.
- Discussion of targeted agent efficacy and toxicity.
Main Results:
- Targeted agents provide statistically significant improvements in progression-free and overall survival.
- These improvements are often clinically modest.
- Differential toxicity profiles exist among various treatment regimens.
Conclusions:
- Statistical significance in survival benefits does not always equate to clinical significance for targeted agents in CRC.
- Individualizing treatment for metastatic colorectal cancer requires careful consideration of both efficacy and toxicity.
- Clinicians must balance the modest gains from targeted therapies against their potential side effects.
Related Concept Videos
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
01:18Second Order systems II
406
In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
406
01:21First Order Systems
428
First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
428
01:20Second Order systems I
598
A servo system exemplifies a second-order system, featuring a proportional controller and load elements that ensure the output position aligns with the input position. The relationship between these components is described by a second-order differential equation. Applying the Laplace transform under zero initial conditions yields the transfer function, showing how inputs are converted to outputs in the system.
By reinterpreting the system, one can derive the closed-loop transfer function, which...
By reinterpreting the system, one can derive the closed-loop transfer function, which...
598